[go: up one dir, main page]

ATE289997T1 - Herstellung von warfarin-natrium aus warfarin- säure - Google Patents

Herstellung von warfarin-natrium aus warfarin- säure

Info

Publication number
ATE289997T1
ATE289997T1 AT01991574T AT01991574T ATE289997T1 AT E289997 T1 ATE289997 T1 AT E289997T1 AT 01991574 T AT01991574 T AT 01991574T AT 01991574 T AT01991574 T AT 01991574T AT E289997 T1 ATE289997 T1 AT E289997T1
Authority
AT
Austria
Prior art keywords
warfarin
sodium
acid
production
low temperature
Prior art date
Application number
AT01991574T
Other languages
English (en)
Inventor
Michel Ashkar
Sorin Bercovici
Robert Graf
Original Assignee
Taro Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taro Pharma Ind filed Critical Taro Pharma Ind
Application granted granted Critical
Publication of ATE289997T1 publication Critical patent/ATE289997T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C07D311/46Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
AT01991574T 2001-02-28 2001-12-28 Herstellung von warfarin-natrium aus warfarin- säure ATE289997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/794,212 US6673944B2 (en) 2001-02-28 2001-02-28 Preparation of warfarin sodium from warfarin acid
PCT/US2001/050512 WO2002070505A1 (en) 2001-02-28 2001-12-28 Preparation of warfarin sodium from warfarin acid

Publications (1)

Publication Number Publication Date
ATE289997T1 true ATE289997T1 (de) 2005-03-15

Family

ID=25162028

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01991574T ATE289997T1 (de) 2001-02-28 2001-12-28 Herstellung von warfarin-natrium aus warfarin- säure

Country Status (13)

Country Link
US (1) US6673944B2 (de)
EP (1) EP1363894B1 (de)
JP (1) JP2004520427A (de)
CN (1) CN1492862A (de)
AT (1) ATE289997T1 (de)
BR (1) BR0116918A (de)
CA (1) CA2438407A1 (de)
DE (1) DE60109212T2 (de)
ES (1) ES2239169T3 (de)
IL (1) IL157553A0 (de)
MX (1) MXPA03007768A (de)
RU (1) RU2003129001A (de)
WO (1) WO2002070505A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8327137B1 (en) * 2005-03-25 2012-12-04 Advanced Micro Devices, Inc. Secure computer system with service guest environment isolated driver
US7259185B2 (en) 2005-06-15 2007-08-21 Morton Grove Pharmaceuticals, Inc. Stable warfarin sodium liquid formulation and method of making same
WO2008044246A2 (en) * 2006-10-10 2008-04-17 Matrix Laboratories Ltd A process for the preparation of warfarin sodium
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
CA2800016A1 (en) * 2010-05-20 2011-11-24 Apotex Pharmachem Inc. Polymorphic forms of warfarin potassium and preparations thereof
WO2011145007A1 (en) 2010-05-20 2011-11-24 Alembic Pharmaceuticals Limited A process for the preparation of amorphous warfarin sodium

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2427578A (en) 1945-04-02 1947-09-16 Wisconsin Alumni Res Found 3-substituted 4-hydroxycoumarin and process of making it
US2777859A (en) 1953-02-05 1957-01-15 Wisconsin Alumni Res Found Warfarin-alkali metal derivatives and processes of preparing the same
US2752360A (en) 1953-03-23 1956-06-26 S B Penick & Company Inc Improvement in the manufacture of 3-substituted 4-hydroxycoumarins
US2765321A (en) 1955-05-27 1956-10-02 Wisconsin Alumni Res Found Process of making crystalline warfarin sodium
US3192232A (en) 1961-02-21 1965-06-29 Wisconsin Alumni Res Found Warfarin alkali metal derivative process
USRE25866E (en) 1961-02-21 1965-09-21 Warfarin sodium
US3239529A (en) 1962-03-01 1966-03-08 Wisconsin Alumni Res Found Resolution of warfarin and marcoumar
US3246013A (en) 1963-02-15 1966-04-12 Wisconsin Alumni Res Found Preparation of crystalline warfarin sodium-isopropyl alcohol complex
FR1397213A (fr) * 1963-05-14 1965-04-30 Frosst & Co Charles E Nouveau procédé de préparation de la warfarine-sodium
US4113744A (en) 1974-08-13 1978-09-12 Nasri W. Badran Microcrystalline 3-(alpha-acetonylbenzyl)-4-hydroxycoumarin (warfarin) and methods of making
DE3142985A1 (de) 1981-10-29 1983-05-11 Gebrüder Lödige Maschinenbau-Gesellschaft mbH, 4790 Paderborn Verfahren und vorrichtung zum entfernen von loesungsmitteln aus schuettguetern
US4826689A (en) 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
ZA965853B (en) 1995-07-13 1998-01-12 Du Pont Merck Pharma Asymmetric synthesis of r and s warfarin and its analogs.
AU6675696A (en) 1995-07-13 1997-02-10 Du Pont Merck Pharmaceutical Company, The A novel asymmetric synthesis of r and s warfarin and its analogs
US5696274A (en) 1995-12-28 1997-12-09 Hoechst Celanese Corporation Syntheses based on 2-hydroxyacetophenone

Also Published As

Publication number Publication date
BR0116918A (pt) 2004-04-27
WO2002070505A1 (en) 2002-09-12
JP2004520427A (ja) 2004-07-08
RU2003129001A (ru) 2005-02-27
CA2438407A1 (en) 2002-09-12
EP1363894B1 (de) 2005-03-02
IL157553A0 (en) 2004-03-28
CN1492862A (zh) 2004-04-28
US20020120157A1 (en) 2002-08-29
EP1363894A1 (de) 2003-11-26
US6673944B2 (en) 2004-01-06
MXPA03007768A (es) 2004-11-12
DE60109212D1 (de) 2005-04-07
ES2239169T3 (es) 2005-09-16
DE60109212T2 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
DE60332776D1 (de) Herstellung von Delta-9-Tetrahydrocannabinol
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
DK1222173T3 (da) Fremgangsmåde til fremstilling af 4-trifluormethylsulphinylpyrazolderivat
DE60307268D1 (de) Pestizide pyridincarbonsäureamidderivate
EA200500368A1 (ru) Фунгицидная композиция, содержащая масло чайного дерева
CA2325919A1 (en) Processes for the preparation of threo-1,2-epoxy-3-amino-4-phenylbutane derivatives
ATE289997T1 (de) Herstellung von warfarin-natrium aus warfarin- säure
NO20080812L (no) Fremgangsmate for fremstilling av 4 β-amino-4'demetyl-4-4-desoksy podofyllotoksin
ATE517857T1 (de) Herstellung von 4-phenylbutansäure
MXPA04006803A (es) Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma.
DE69513657D1 (de) Verfahren zur Herstellung von 1-substituierten 2-Cyanoimidazolen
DE60211758D1 (de) Verfahren zur herstellung von sulfinylderivaten mittels oxidation der entsprechenden sulfide
ATE406349T1 (de) Herstellung von astaxanthin
AU2001281883A1 (en) Method for producing 2-alkyl-3-aryl- and -heteroaryloxaziridines and novel 2-alkyl-3-aryloxaziridines
AU2003266093A1 (en) Cyclooct-(en-)yl derivatives for use as fragrances
DK1678129T3 (da) Forbedret fremgangsmåde til fremstilling af benzhydrylthioacetamid
NO20064273L (no) Fremgangsmate for semisyntese av deserpidin
NO20011031L (no) Fremgangsmåte for fremstilling av N-beskyttede azetidin-2- karboksylsyrer (AzeOHs)
HUP0400825A2 (hu) Eljárás amorf cilastatin nátrium előállítására
CA2500330A1 (en) Processes for preparation of organic compounds
AR046987A1 (es) Procedimiento para la preparacion de triazolopirimidinas
ATE356118T1 (de) Moexipril-magnesium enthaltende arzneimittel
UY27693A1 (es) Procedimiento para la síntesis de cloroadenosina y metiltioadenosina.
RU94033536A (ru) Способ получения 2,6-ди-(4-гидрокси-3-метоксибензилиден)-циклогексанона
DE60029771D1 (de) Verfahren zur herstellung von 3,4-dihydrobutansäure und derivaten davon aus substituierten pentosezuckern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties